Related Articles

• The TLR4/ERK/PD‑L1 axis may contribute to NSCLC initiation
• Preliminary mechanisms of regulating PD‑L1 expression in non‑small cell lung cancer during the EMT process
• The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
• The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence
• PD‑L1 promotes head and neck squamous cell carcinoma cell growth through mTOR signaling